During the past decade, Mary Potter Oncology Centre conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 7 clinical trials were completed, i.e. on average, 140% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Mary Potter Oncology Centre" #1 sponsor was "Pfizer" with 3 trials, followed by "Celgene" with 2 trials sponsored, "Takeda" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mary Potter Oncology Centre" #1 collaborator was "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Mary Potter Oncology Centre" are "Melanoma" (2 trials), "Multiple Myeloma" (2 trials), "Autologous Stem Cell Transplant" (1 trials), "B-Cell Chronic Lymphocytic Leukemia" (1 trials) and "B-cell Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Mary Potter Oncology Centre" in a lesser frequency.

Most popular intervention types in "Mary Potter Oncology Centre" are "Drug" (11 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lenalidomide" (2 trials), "MEK162" (2 trials), "5-FU" (1 trials) and "Avelumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mary Potter Oncology Centre" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Mary Potter Oncology Centre". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Mary Potter Oncology Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mary Potter Oncology Centre, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Mary Potter Oncology Centre has several departments that took part in Clinical trials: "Mary Potter Oncology Centre" - 5 trials